PlainRecalls
FDA Drug Moderate Class II Ongoing

Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.

Reported: December 7, 2022 Initiated: November 16, 2022 #D-0071-2023

Product Description

Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.

Reason for Recall

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Details

Recalling Firm
Noven Pharmaceuticals Inc
Units Affected
3977 boxes
Distribution
Nationwide in the USA
Location
Miami, FL

Frequently Asked Questions

What product was recalled?
Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.. Recalled by Noven Pharmaceuticals Inc. Units affected: 3977 boxes.
Why was this product recalled?
Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 7, 2022. Severity: Moderate. Recall number: D-0071-2023.